Legal Representation
Attorney
John Patrick Sullivan
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 3, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 3, 2022 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 3, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 16, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 17, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 20, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Herbal tinctures for medical purposes; dietary supplements for humans; medicated oils containing full spectrum hemp oil; dietary beverage supplements for human consumption for therapeutic purposes; herbal bitters as a dietary supplement; herbal tonic supplements, all of the aforementioned goods containing hemp solely with a delta-9 tetrahydrocannabinol thc concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring cbd; pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treatment of opioid addiction with pain management; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations, namely, antidepressants; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations in the form of topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves for treating chemical imbalances, inflammation, epilepsy, depression, cancer, and opioid addiction with pain management; all of the foregoing containing or solely derived from CBD derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; anti-epileptic pharmaceutical preparations containing no CBD
First Use Anywhere:
Sep 24, 2020
First Use in Commerce:
Sep 24, 2020
Class 044
Dispensing of pharmaceuticals containing or solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis; dispensing of pharmaceuticals containing no CBD; dispensing of herbal tinctures, dietary supplements for humans, medicated oils containing full spectrum hemp, dietary beverage supplements for human consumption for therapeutic purposes, herbal bitters as a dietary supplement, and herbal tonic supplements
First Use Anywhere:
Sep 24, 2020
First Use in Commerce:
Sep 24, 2020
Classification
International Classes
005
044